Keywords: biogen, sees, first, launch, ms, drug, avonex

Biogen Sees First Launch Of MS Drug Avonex

Article | 27 May 1996

Print This

Biogen' interferon beta-1a product Avonex has been approved for marketing in the USA for the treatment of relapsing forms ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in